Chimerix (CMRX) Tops Q2 EPS by 5c

Chimerix (NASDAQ: CMRX) reported Q2 EPS of ($0.39), $0.05 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $919 thousand versus the consensus estimate of $740 thousand.

For earnings history and earnings-related data on Chimerix (CMRX) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Radnostix revenue falls 27% amid product recalls and FDA actions
• SuperCom (SPCB) Tops Q3 EPS by 43c